[1] Zhang Yong, Li Yuan,.A Clinical Study on the Treatment of the Cerebral Arteriosclerosis with Deficiency of Kidney and Blood Stasis by the Jiannao Bushen Tongluo Prescription [J]. Modern Traditional Chinese Medicine, 2020, (04): 68-71. [doi: 10.13424/j.cnki.mtcm.2020.04.017]
A Clinical Study on the Treatment of the Cerebral Arteriosclerosis with Deficiency of Kidney and Blood Stasis by the Jiannao Bushen Tongluo Prescription
- Article number:
- 1672-0571(2020)04-0068-04
- Keywords:
- the Jiannao Bushen Tongluo Prescription; deficiency of kidney and blood stasis ; Cerebral Arteriosclerosis; the blood lipid metabolism; the cerebral blood flow
- ZTFLH:
- R255.2
- Code:
- A
- Abstract:
- Objective To explore the influence on the blood lipid metabolism and cerebral blood flow parameters of the patients with the cerebral arteriosclerosis with deficiency of kidney and blood Stasis by use of the Jiannao Bushen Tongluo ( Brain - invigorating and Spleen - tonifying to Dredge the Collateral) Prescription. Method To select the 60 cases of hospitalized patients suffering from the cerebral arteriosclerosis with deficiency of kidney and blood stasis ranging from Jan. in 2012 to Dec. in 2018 as the objects and randomly divide them into the control group( n =30) and observation group( n =30) . The former is given the regular treatment of western medicine, and the latter is given the Jiannao Bushen Tongluo Prescription. Then the overall effect rate and the blood lipid metabolism and cerebral blood flow parameters in the two groups are compared. Result After the treatment, the control group is obviously higher than the observation group in the overall effect rate with significant difference( p < 0. 05) ; the observation group is superior to its counterpart in the the blood lipid metabolism and cerebral blood flow parameters with significant difference( p <0. 05) . Conclusion The effectiveness is significant in treating the patients suffering from the cerebral arteriosclerosis with deficiency of kidney and blood stasis by use of the Jiannao Bushen Tongluo Prescription, and the the blood lipid metabolism and cerebral blood flow parameters can be effectively improved, thus it is worthwhile to popularize the prescription.
References:
[1]吴晓峰,李文玉,李志丹,等.通脑方治疗脑动脉硬化症的疗效以及对血脂?Hcy水平的影响[J].四川中医,2018,36(4):116-119.
[2]姜楠,潘赐明,赵黎.李氏当归补血汤治疗血虚发热再议[J].现代中医药,2019,39(4)76-80.
[3]袁兴建.化瘀通脑汤治疗脑动脉硬化症(痰瘀互结型)的疗效和对脑血流动力学的 影 响 [J].四川中医,2017,45(10):108-111.
[4]刘纳新.盐酸氟桂利嗪治疗脑动脉硬化症对患者血液流变学及血流动力学指标影响[J].创伤与急危重病医学,2018,6(1):57-59.
[5]衣卫东,苑冰,梁志敏,等.益气活血通脉方治疗糖尿病下肢动脉硬化闭塞症临床研究 [J].中医学报,2017,32(9):1630-1632.
[6]史英,郑荣心,张莹,等.结肠止泻汤治疗溃疡性结肠炎脾虚湿阻证的临床研究[J].现代中医药,2019,39(4):76-80.
[7]刘欣燕,刘笑迎.扶阳软坚清脉方治疗肢体动脉硬化闭塞症疗效观察[J].人民军医,2019,62(1):72-75.
[8]周思.生脉饮合黄芪桂枝五物汤加减方治疗糖尿病性下肢动脉硬化闭塞症的效果分析[J].当代医药论丛,2019,17(5):188-189.
[9]袁有才,宋轩,曹,等.调脂柔脉颗粒对症状性颈动脉粥样硬化血脂及颈内膜作用的临床研究[J].现代中医药,2018,38(05):21-24.
[10]付良,潘彦,熊文清.黄芝通脑络胶囊改善脑动脉硬化症患者脑血流的临床观察[J].陕西中医药大学学报,2012,35(3):37-39.
[11]孔宁.高压氧辅助治疗脑动脉硬化症患者脑血流的临床观察[J].首都食品与医药,2017,24(10):62-63.
[12]梁健,张倩.盐酸氟桂利嗪治疗脑动脉硬化症的临床疗效及不良反应观察[J].贵州医药,2017,41(5):499-501.
Memo
作者简介:张勇(1978-),男,副主任医师,研究方向:E-mail:xihz29703538@163.com